In one paragraphArticle in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Yuanyuan Tang *College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.ORCID 0009-0009-2963-182X Yuqing Xia *College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
Xuancheng Huang *Department of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Shenzhen Nanshan People's Hospital, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.
Zhijian YuDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Shenzhen Nanshan People's Hospital, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.ORCID 0000-0002-5677-2064 Duoyun LiDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Shenzhen Nanshan People's Hospital, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.ORCID 0009-0004-4313-4487 Shiqing HanCollege of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.ORCID 0000-0002-9867-0947 Peiyu LiDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Shenzhen Nanshan People's Hospital, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.ORCID 0000-0002-1001-7485 Tieying HouDepartment of Infectious Diseases and Shenzhen Key Laboratory for Endogenous Infections, Shenzhen Nanshan People's Hospital, Affiliated Nanshan Hospital of Shenzhen University, Shenzhen, China.ORCID 0000-0002-3902-2632 Funding
Basic and Applied Basic Research Foundation of Guangdong Province 2023A1515220082Medical Scientific Research Foundation of Guangdong Province of China A2023468, A2024364Municipal Financial Subsidy of Nanshan District Meclcal Key Disciplne Construction FundMunicipal Financial Subsidy of Shenzhen Medical Key Discipline Construction Fund SZXK06162National Natural Science Foundation of China 82172283Sanming Project of Medicine in Shenzen Municipality SZSM202303037Science, Technology and Innovation Commission of Shenzhen Municipality JCYJ20230807115814030, JCYJ20220530141615035, JCYJ20240813114503005Shenzhen Municipal Science and Technology Innovation Council KJZD20240903103500002Shenzhen Nanshan District Scientific Research Program NS2023035, NS2023049, NS2024007, NS2024014, NSZD2024023, NS2025005, NSZD2024038
6 · The paper itselfAbstract
IMPORTANCE: Antibiotic resistance and the formation of biofilms, which protect bacteria from medications and immunological responses, present the significant challenges for the clinical treatment of
Indexed as
Anti-Bacterial AgentsCell MembraneStaphylococcus aureusBiofilmsDrug RepositioningHumansMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsStaphylococcal InfectionsAnti-Bacterial Agentsantibacterial activitybiofilmsmembrane integritymocravimod hydrochloridesphingosine-1-phosphate receptor modulatorStaphylococcus aureus
Identifiers
PMID42505145
PMCPMC13532308
What OpenQuestion holds
Textmetadata
Read underepoch 390